CATEGORY HUB
Women's Health
Women's Health verdicts ranked by evidence score. 177 verdicts in this category.
51 foods and supplements claimed to help women's health, ranked by evidence
Drugs and procedures removed — only what you swallow, ordered by how strong the evidence is.
Women's Health Evidence Ranking
Within this category, verdicts with higher evidence scores appear first. Verdicts without a score stay lower in the same list.
| A | 96 | Tamoxifen citrate (selective estrogen receptor modulator and prescription medicine) | Reduced recurrence and breast-cancer mortality after surgery for estrogen-receptor-positive early breast cancer |
| A | 96 | Trastuzumab (anti-HER2 monoclonal antibody; prescription biologic, Herceptin) | Reduced recurrence and mortality after surgery and chemotherapy for HER2-positive early breast cancer |
| A | 96 | Magnesium sulfate (inorganic magnesium salt anticonvulsant; prescription intravenous or intramuscular injection) | Prevention of eclamptic seizures in pregnant women with pre-eclampsia |
| A | 94 | Antenatal betamethasone (long-acting glucocorticoid given by prescription intramuscular injection) | Reduced neonatal and perinatal death and respiratory distress syndrome in imminent preterm birth at 24 to 34 weeks |
| A | 94 | Immediate kangaroo mother care (immediate KMC, neonatal care based on skin-to-skin contact and breast-milk feeding) | Reduced neonatal mortality in preterm or low-birth-weight infants |
| A | 93 | Deferred or delayed cord clamping in preterm birth (a delivery procedure) | Reduced neonatal death before hospital discharge among infants born preterm |
| A | 92 | Low-dose aspirin, 81 to 150 mg, an antiplatelet medicine available by prescription or without prescription depending on jurisdiction | Prevention of preterm preeclampsia when a high-risk pregnant patient takes it after 12 weeks of gestation under clinician direction |
| A | 91 | Tdap vaccine (non-live combination of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis antigens; prescription vaccine including Boostrix) | Prevention of pertussis and pertussis hospitalization in early infancy through vaccination at 27 to 36 weeks of pregnancy |
| A | 90 | High-risk human papillomavirus testing for cervical-cancer screening | Prevention of invasive cervical cancer compared with cytology |
| A | 88 | Estradiol (prescription estrogen hormone-replacement therapy; Progynova) | Reduction of moderate-to-severe menopausal hot flashes and vasomotor symptoms |
| A | 88 | Tamoxifen 20 mg daily for five years as prevention | Reduced breast-cancer incidence in high-risk women without breast cancer |
| A | 86 | Letrozole (aromatase inhibitor, Femara, prescription medicine; off-label for infertility) | Increased ovulation and live birth in women with anovulatory PCOS infertility |
| A | 80 | Desogestrel/ethinyl estradiol (prescription combined oral contraceptive; Mercilon) | Prevention of pregnancy through ovulation suppression when taken correctly |
| B | 79 | Magnesium sulfate (inorganic magnesium salt administered as an intravenous prescription injection) | Reduced childhood cerebral palsy and the composite of death or cerebral palsy when given before imminent birth before 32 weeks for fetal neuroprotection |
| B | 78 | Metronidazole (prescription nitroimidazole antimicrobial; Flagyl) | Reduced discharge and odor and clinical cure of symptomatic bacterial vaginosis |
| B | 77 | Levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena, prescription device) | Improved menstrual blood loss and quality of life in idiopathic heavy menstrual bleeding |
| B | 77 | Oxytocin (prescription intramuscular or intravenous uterotonic peptide hormone) | Reduced postpartum hemorrhage and transfusion risk with prophylaxis immediately after birth |
| B | 77 | Maternal bivalent RSV prefusion-F vaccine (RSVpreF, Abrysvo, intramuscular prescription vaccine during pregnancy) | Prevention of severe RSV lower respiratory tract illness in infants through 6 months of age by maternal vaccination |
| B | 76 | Tranexamic acid (antifibrinolytic hemostatic medicine, prescription intravenous injection) | Reduced death due to bleeding when given within three hours of birth for clinically diagnosed postpartum hemorrhage |
| B | 76 | Capecitabine (an oral fluoropyrimidine prodrug and prescription anticancer medicine) | Reduced recurrence and death in residual HER2-negative breast cancer after neoadjuvant chemotherapy |
| B | 76 | Exemestane (steroidal aromatase inhibitor; oral prescription medicine marketed as Aromasin) | Primary prevention of invasive breast cancer in high-risk postmenopausal women |
| B | 76 | Metronidazole 500 mg twice daily for seven days | Reduced persistent infection or positive test of cure in women with trichomoniasis |
| B | 76 | Prophylactic human papillomavirus vaccination | Reduced incidence of invasive cervical cancer |
| B | 76 | Two years of adjuvant abemaciclib added to standard endocrine therapy | Reduction of invasive recurrence in hormone receptor-positive, HER2-negative, node-positive high-risk early breast cancer |
| B | 76 | Repeated single-embryo transfer | Reduction of multiple birth in good-prognosis IVF |
| B | 76 | Planned labor induction at 39 weeks | Perinatal outcomes and cesarean delivery in low-risk nulliparous women |
| B | 76 | Oral conjugated equine estrogen 0.625 mg plus medroxyprogesterone acetate | Increased pulmonary embolism |
| B | 76 | A bundled active-management strategy for the third stage of labor | Reduced postpartum hemorrhage of at least 500 mL versus physiological or expectant management |
| B | 76 | A lying-down policy keeping the pelvis as horizontal as possible during second-stage labor in nulliparous women with low-dose epidural analgesia | Increased spontaneous vaginal birth versus an upright policy |
| B | 76 | Low-dose aspirin 81 mg daily started at 6 weeks 0 days to 13 weeks 6 days of pregnancy | Prevention of delivery before 37 weeks in nulliparous singleton pregnancies in low-resource countries |
| B | 76 | E-MOTIVE, combining a calibrated blood-collection drape with concurrent first-response treatment | Reduced severe postpartum hemorrhage, laparotomy for bleeding, or death from bleeding after vaginal birth |
| B | 76 | An antihypertensive strategy treating mild chronic hypertension during pregnancy to below 140/90 mm Hg | Reduction of a composite of severe preeclampsia, medically indicated preterm birth, placental abruption, or fetal or neonatal death |
| B | 76 | Antenatal dexamethasone for women at risk of early preterm birth | Reduced neonatal death and stillbirth-or-neonatal-death in low-resource hospitals |
| B | 76 | Simple hysterectomy with lymph-node assessment | Noninferiority to radical hysterectomy for three-year pelvic recurrence in early low-risk cervical cancer |
| B | 75 | Ibuprofen, a nonsteroidal anti-inflammatory drug available over the counter and by prescription | Relief of pain and daily-life impairment from primary dysmenorrhea |
| B | 75 | Linzagolix (Yselty, prescription oral GnRH antagonist) | Reduction of uterine-fibroid-associated heavy menstrual bleeding to the clinical response threshold |
| B | 74 | DHA and long-chain omega-3 fatty acids during pregnancy | Reduced risk of preterm and early preterm birth |
| B | 74 | Anastrozole (nonsteroidal aromatase inhibitor; Arimidex; prescription anticancer medicine) | Prevention of recurrence after surgery for hormone-receptor-positive early breast cancer in postmenopausal women |
| B | 74 | Cervical cerclage (McDonald or Shirodkar technique, prescription obstetric procedure) | Prevention of previable birth, perinatal death, and preterm birth in singleton pregnancies with a prior spontaneous birth before 34 weeks and a short midtrimester cervix |
| B | 74 | Elinzanetant 120 mg, oral capsules, a nonhormonal prescription drug | Reduced frequency and severity of moderate-to-severe menopausal hot flashes and night sweats |
| B | 73 | Ulipristal acetate (selective progesterone receptor modulator, ellaOne, prescription medicine) | Emergency contraception and pregnancy prevention within 120 hours after unprotected intercourse |
| B | 72 | Tranexamic acid (prescription antifibrinolytic; Doransamin) | Reduction of menstrual blood loss in idiopathic or functional heavy menstrual bleeding |
| B | 72 | Levonorgestrel (NorLevo, single-agent emergency contraceptive pill) | Emergency contraception and pregnancy prevention after unprotected intercourse |
| B | 72 | Fluconazole, a prescription triazole antifungal sold including as Diflucan | Six-month suppression and reduced recurrence of recurrent vulvovaginal candidiasis |
| B | 72 | Clomiphene citrate (a prescription selective estrogen receptor modulator, or SERM) | Increased ovulation, clinical pregnancy, and live birth in women with PCOS-related anovulatory infertility |
| B | 72 | Ribociclib (CDK4/6 inhibitor; prescription anticancer drug, Kisqali) | Prolonged overall survival with first-line ribociclib plus letrozole in HR-positive, HER2-negative advanced breast cancer |
| B | 72 | Mirvetuximab soravtansine (folate receptor alpha-targeted antibody-drug conjugate; prescription anticancer infusion; Elahere) | Prolonged overall survival versus single-agent chemotherapy in folate receptor alpha-high platinum-resistant ovarian cancer |
| B | 72 | Olaparib (PARP-inhibitor targeted anticancer drug, Lynparza, prescription medicine) | Reduction of invasive recurrence and death after surgery for germline BRCA1/2-mutated, HER2-negative, high-risk early breast cancer |
| B | 72 | Pelvic floor muscle training for women, also called Kegel exercise | Reduced leakage and symptoms of female stress urinary incontinence |
| B | 72 | Combined oral contraceptive containing estrogen and progestin | Relief of primary dysmenorrhea |
| B | 72 | Raloxifene 60 mg daily for five years | Primary prevention of breast cancer in high-risk postmenopausal women |
| B | 72 | Warm perineal compresses during the second stage of labor | Reduced third- and fourth-degree perineal tears |
| B | 72 | One intravenous dose of amoxicillin 1 g plus clavulanic acid 200 mg within six hours after forceps or vacuum birth | Reduced maternal infection within six weeks after birth |
| B | 72 | Caseload midwifery continuity through pregnancy, birth, and postpartum care | Reduced caesarean birth among women at low obstetric risk |
| B | 72 | Omission of sentinel lymph node biopsy | De-escalation preserving five-year distant disease-free survival in small breast cancer with negative axillary ultrasonography |
| B | 72 | Single blastocyst-stage embryo transfer | Cumulative live birth after up to three transfers versus cleavage-stage transfer |
| B | 72 | Laparoscopic bilateral salpingectomy | Noninferiority to tubal occlusion for surgical complications through eight weeks after permanent contraception |
| B | 72 | Delayed second-procedure TARGIT intraoperative radiotherapy | Increased five-year local recurrence in the conserved breast and failed noninferiority versus whole-breast external-beam radiotherapy |
| B | 70 | Mefenamic acid (prescription fenamate NSAID, including Ponstel) | Reduction of pain and need for additional analgesics in primary dysmenorrhea |
| B | 70 | Azithromycin (macrolide antibiotic, prescription drug) | Reduced composite of postpartum maternal sepsis or death after a single 2-g intrapartum dose in women planning vaginal birth; the standalone maternal-mortality effect was null |
| B | 70 | Screening mammography (low-dose breast radiography) | Reduced breast cancer mortality through regular screening of women in their 40s |
| B | 70 | Nitrofurantoin (urinary antibiotic) | Symptom resolution and clinical cure of acute uncomplicated cystitis in women |
| B | 70 | Naproxen, a nonselective NSAID | Relief of primary dysmenorrhea |
| B | 70 | Antenatal digital perineal massage performed by the woman or her partner from 34 to 35 weeks | Reduced episiotomy and suturing-requiring perineal trauma at vaginal birth |
| B | 69 | 4% chlorhexidine cord care (an antiseptic-based neonatal procedure and WHO essential medicine) | Prevention of omphalitis and neonatal death in settings with unhygienic cord practices |
| B | 68 | Clotrimazole vaginal tablet (topical azole antifungal, Canesten, nonprescription or prescription) | Clinical and mycological cure of uncomplicated vulvovaginal candidiasis |
| B | 68 | Carbetocin (long-acting oxytocin-receptor agonist uterotonic, prescription injection; Duratocin) | Prevention of postpartum hemorrhage and severe postpartum hemorrhage when given immediately after birth |
| B | 66 | Dienogest (progestin, Visanne, prescription) | Reduction of endometriosis-associated pelvic pain and dysmenorrhea |
| B | 64 | Paroxetine (prescription SSRI; low-dose 7.5 mg for menopausal hot flashes) | Reduced moderate-to-severe menopausal hot flashes and night sweats |
| B | 64 | Fezolinetant, a prescription nonhormonal neurokinin-3 receptor antagonist marketed as Veozah | Reduced frequency and severity of moderate-to-severe menopausal hot flashes and night sweats |
| B | 64 | Sacral neuromodulation with an implanted InterStim-type neurostimulator | Improvement of refractory overactive bladder and urgency urinary incontinence |
| B | 63 | Complex extract including Cynanchum wilfordii (EstroG-100: Cynanchum wilfordii/Cynanchum, Phlomis umbrosa, and Angelica gigas complex) and pomegranate extract/pomegranate concentrate | Relief of menopausal symptoms in women |
| B | 62 | Tibolone (synthetic steroid, Livial, prescription medicine) | Relief of postmenopausal vasomotor symptoms such as hot flashes and night sweats |
| B | 62 | Fosfomycin trometamol (a prescription phosphonic-acid antibiotic) | Clinical cure of acute uncomplicated cystitis in nonpregnant women with a single 3-g dose |
| B | 60 | Vitamin B6 (pyridoxine) | PMS (premenstrual syndrome) and morning sickness |
| C | 59 | Vaginal micronized progesterone (prescription progestogen; preterm-birth prevention may be off-label in Korea) | Prevention of spontaneous birth before 34 weeks in mid-trimester singleton pregnancy with a short cervix |
| C | 58 | Chasteberry (Vitex agnus-castus/chasteberry) | PMS and premenstrual syndrome |
| C | 58 | Siberian rhubarb extract (ERr 731) | Relief of menopausal hot flashes and symptoms |
| C | 58 | Vaginal estriol (Ovestin vaginal suppository, prescription local estrogen) | Relief of vaginal dryness, pain, and dyspareunia in genitourinary syndrome of menopause |
| C | 58 | Postnatal breastfeeding counselling and support (professional or peer support program) | Improved continuation of any and exclusive breastfeeding at six months |
| C | 57 | Ginger root powder or extract from Zingiber officinale | Pain relief in primary dysmenorrhea |
| C | 56 | Inositol (myo-inositol/D-chiro-inositol) | PCOS, mood, and blood glucose |
| C | 56 | Drospirenone and ethinyl estradiol 24/4 combination (Yaz, prescription) | Improvement in emotional and physical symptoms and daily functioning in premenstrual dysphoric disorder |
| C | 56 | Methenamine hippurate (non-antibiotic urinary antiseptic) | Noninferior prevention of recurrent urinary tract infection in women versus antibiotic prophylaxis |
| C | 56 | Vaginal estrogen (local prescription estriol or estradiol cream or ring) | Prevention of recurrent urinary tract infection after menopause |
| C | 56 | Soy foods after breast-cancer diagnosis | Lower breast-cancer recurrence and mortality |
| C | 56 | At least 2.3 daily servings of produce classified as high-residue using US surveillance data | Lower clinical-pregnancy and live-birth success per assisted-reproduction cycle |
| C | 56 | Plastic contact from food and kitchenware with internal phthalate and bisphenol exposure | Reduced clinical pregnancy and live birth after in vitro fertilization |
| C | 56 | Oral contraceptives | Reduced ovarian-cancer incidence |
| C | 56 | Levonorgestrel 52 mg intrauterine device | Emergency contraception within five days after unprotected intercourse |
| C | 56 | Cefazolin 2 g intravenously 20-30 minutes before cesarean skin incision | Prevention of maternal infection versus the same antibiotic after cord clamping |
| C | 56 | Use of hair straighteners, relaxers, or pressing products | Associated with increased incidence of uterine cancer |
| C | 56 | Adjuvant radiotherapy, 26 Gy in five fractions over one week after surgery | Noninferior prevention of five-year ipsilateral breast tumor relapse versus 40 Gy in 15 fractions over three weeks |
| C | 56 | Direct mailing of HPV self-sampling kits | Increased six-month cervical screening completion among adults who were overdue or long-term non-attenders |
| C | 56 | Risk-based breast cancer screening | Noninferior stage IIB or higher breast cancer versus annual screening |
| C | 54 | Flaxseed (lignans, flaxseed) | menopausal symptoms (hot flashes/night sweats), gut health (constipation/bowel movements), cholesterol (LDL/total cholesterol) |
| C | 54 | S-equol, a soy-derived fermentation metabolite | Relief of menopausal hot flashes, sleep disturbance, and muscle pain |
| C | 54 | Elagolix (prescription oral GnRH antagonist) | Response in endometriosis-associated dysmenorrhea and nonmenstrual pelvic pain |
| C | 54 | Whole lettuce | Reduced incidence of estrogen-receptor-negative breast cancer |
| C | 54 | Whole date fruit, 100 g | Reduced bleeding during 24 hours after vaginal delivery |
| C | 54 | An additional 1.5 L of water per day on top of usual intake | Prevention of recurrent cystitis in premenopausal women with low baseline fluid intake |
| C | 54 | A non-rigid lumbopelvic support belt worn during waking hours and removed for sleep | Relief of pregnancy-related pelvic girdle pain and disability at 20-32 weeks' gestation |
| C | 54 | Menstrual cup use | Associated with increased copper intrauterine-device expulsion |
| C | 54 | Intensive physiotherapist-supervised pelvic floor muscle training from 20 to 36 weeks of pregnancy | Primary prevention of urinary incontinence in late pregnancy and three months postpartum |
| C | 54 | Preoperative office evaluation alone, omitting routine urodynamic testing | Noninferiority to added urodynamic testing for one-year patient-reported treatment success in uncomplicated stress urinary incontinence |
| C | 53 | Lactobacillus acidophilus YT1 (MENOLACTO®, an individually recognized branded strain) | Improved menopausal symptoms, including hot flashes, and quality of life |
| C | 52 | Fennel seed extract | Relief of menopausal symptoms |
| C | 52 | Coenzyme Q10 | Improved IVF or ICSI pregnancy success in women with diminished ovarian reserve |
| C | 52 | Saffron, a Crocus sativus extract | Relief of mood and physical symptoms of PMS or PMDD |
| C | 50 | MS-10 thistle complex | Relief of menopausal symptoms in women |
| C | 50 | UREX probiotics GR-1 plus RC-14 (L. rhamnosus GR-1 plus L. reuteri RC-14) | Growth of beneficial vaginal bacteria and reduction of bacterial-vaginosis recurrence |
| C | 50 | Local superficial heat therapy (abdominal heat patch or heating pad) | Relief of pain from primary dysmenorrhea |
| C | 50 | Cold cabbage leaves applied twice in addition to usual breast-engorgement care | Short-term relief of pain and hardness from postpartum breast engorgement |
| C | 49 | Omega-3 fatty acids (EPA and DHA fish-oil supplement; dysmenorrhea efficacy axis) | Reduced pain intensity and analgesic use in primary dysmenorrhea |
| C | 48 | Red clover isoflavones | Relief of menopausal hot flashes and night sweats |
| C | 48 | Shatavari (Asparagus racemosus) | Improvement of menopausal symptoms and female sexual function |
| C | 48 | Fennel seed extract (Foeniculum vulgare) | Reduced pain and analgesic use in primary dysmenorrhea |
| C | 48 | Domperidone (dopamine-antagonist gastroprokinetic used off label as a galactagogue) | Increased milk volume and successful breastfeeding in postpartum women with low milk supply |
| C | 48 | Edible castor oil (ricinoleic-acid-rich vegetable oil, food and nonprescription product) | Promotion of spontaneous labor onset within 24 hours and vaginal delivery after oral ingestion at term or post-term |
| C | 46 | Soy isoflavones (soy isoflavones; genistein, daidzein, glycitein, etc.) | Menopausal symptoms in women, especially vasomotor symptoms such as hot flashes/night sweats |
| C | 46 | Sophora japonica fruit extract | Menopausal women’s health and improvement in the Kupperman Index |
| C | 46 | Intravaginal boric acid | Treatment of recurrent non-albicans vulvovaginal candidiasis |
| C | 46 | Vaginal hyaluronic acid (topical vaginal gel or cream) | Relief of vaginal dryness, atrophy, and dyspareunia in genitourinary syndrome of menopause |
| C | 43 | Diindolylmethane (DIM) | Estrogen balance and PMS improvement |
| C | 43 | Pueraria mirifica | Breast enlargement, estrogen balance, and relief of menopausal symptoms |
| C | 42 | Gamma-oryzanol (derived from rice bran) | Cholesterol, menopause, autonomic nervous system |
| C | 40 | Germinated fermented soybean extract | Relief of menopausal symptoms in women |
| C | 40 | Motherwort (Leonurus japonicus) | Irregular menstruation, menstrual pain, and postpartum uterine recovery |
| C | 40 | Maca (Lepidium meyenii) | Female desire and sexual function, including antidepressant-associated sexual dysfunction |
| D | 36 | Pueraria root (kudzu root, Pueraria/kudzu, puerarin) | Menopause and hangover |
| D | 34 | WHI low-fat dietary pattern | Reduced invasive breast-cancer incidence in postmenopausal women |
| D | 34 | Switching from caffeinated to decaffeinated instant coffee before 20 weeks' gestation, reducing total caffeine by a mean 182 mg/day | Higher birth weight and longer gestation |
| D | 34 | Second-trimester nonsurgical periodontal treatment with scaling, root planing, and oral-hygiene care | Prevention of birth before 37 weeks in pregnant patients with periodontitis |
| D | 34 | Long-term rotating night-shift history, defined as at least three nights per month plus day or evening shifts | Increased incidence of invasive breast cancer |
| D | 34 | Bra wearing | Higher breast-cancer incidence |
| D | 34 | Endometrial scratching with a Pipelle biopsy catheter before in vitro fertilization | Increase in live birth per randomized woman |
| D | 34 | Endometrial receptivity testing used to personalize embryo-transfer timing | Increase in live birth |
| D | 34 | Time-lapse incubation and morphokinetic embryo selection | Increased live birth after IVF or ICSI |
| D | 34 | Oral gabapentin titrated to a maximum of 2,700 mg daily | Reduced chronic pelvic pain in women without obvious pelvic pathology |
| D | 34 | Levothyroxine 50 micrograms daily started before conception | Increased live birth in euthyroid women positive for thyroid peroxidase antibodies |
| D | 34 | Single preoperative doxycycline 400 mg plus metronidazole 400 mg | Prevention of pelvic infection within 14 days after miscarriage surgery |
| D | 33 | Black cohosh (black cohosh, Cimicifuga/Actaea racemosa) | Menopausal symptoms (hot flashes) |
| D | 32 | Acupuncture for labour induction (acupoint stimulation at term or post-term) | Promotion of spontaneous labour and reduction of medical induction |
| D | 30 | Red raspberry leaf (Rubus idaeus) | Shorter labor, uterine health, and menstrual-pain relief |
| D | 30 | Sea buckthorn berry oil | Relief of postmenopausal vaginal dryness and mucosal atrophy symptoms |
| D | 30 | Dydrogesterone (prescription oral progestogen; Duphaston) | Prevention of miscarriage and increase in live birth across women with threatened miscarriage |
| D | 30 | D-mannose (monosaccharide supplement) | Prevention of recurrent urinary tract infection over six months in women |
| D | 30 | Vaginal micronized progesterone (prescription vaginal formulation) | Increased live birth in women with unexplained recurrent miscarriage |
| D | 30 | Acupuncture (traditional needle-stimulation procedure) | Reduction in frequency and severity of menopausal hot flashes |
| D | 30 | Antiperspirant, deodorant, and underarm shaving | Higher breast-cancer incidence |
| D | 30 | Home or hospital bed rest for threatened miscarriage | Prevention of miscarriage |
| D | 30 | Routine high-volume saline or phosphate enema on admission in labour | Prevention of puerperal and neonatal infection |
| D | 30 | Precision foot reflexology applying pressure to organ-correspondence points | Improved anxiety and depressive symptoms during menopause |
| D | 29 | Cranberry PAC, a berry-polyphenol supplement from Vaccinium macrocarpon containing proanthocyanidins | Antibiotic-replacing symptom resolution and clinical cure of established acute uncomplicated cystitis in women |
| D | 28 | Calcium supplementation | Prevention of preeclampsia and related hypertensive disorders of pregnancy |
| D | 28 | Dong quai (Angelica sinensis single-ingredient capsules) | Improvement of menopausal hot flashes and female hormone balance |
| D | 28 | A single 20-minute postpartum perineal ice-pack application | Relief of perineal pain |
| D | 27 | Wild yam extract | Menopausal symptoms and a 'natural progesterone' effect |
| D | 27 | Intraovarian autologous platelet-rich plasma (self-paid fertility procedure using autologous blood) | Restored ovarian function and increased pregnancy and live birth in women with diminished ovarian reserve or poor response |
| D | 25 | Evening primrose oil (gamma-linolenic acid, GLA; in the domestic market often advertised together with GLA-containing oils such as borage oil and blackcurrant oil) | PMS (discomfort due to premenstrual changes) and skin (immune hypersensitivity/atopic dermatitis, dryness, itching) |
| D | 25 | Seed cycling (a diet alternating flaxseed plus pumpkin seed in the follicular phase with sesame plus sunflower seed in the luteal phase) | Balanced sex hormones, more regular menstrual cycles, and reduced PMS in healthy women |
| D | 24 | Evening primrose oil (a gamma-linolenic-acid-containing botanical oil supplement) | Relief of cyclical mastalgia |
| D | 24 | Cervical pessary (a silicone device placed around the cervix) | Prevention of preterm birth in singleton pregnancy with a short cervix |
| D | 22 | Regular breast self-examination taught and performed monthly | Earlier breast cancer detection and lower breast cancer mortality |
| D | 22 | CA-125 plus transvaginal-ultrasound ovarian cancer screening in asymptomatic women at average risk | Earlier detection and lower ovarian or tubal cancer mortality |
| F | 18 | Dehydroepiandrosterone (DHEA; an adrenal androgen-precursor steroid sold as a supplement in some countries) | Improved live-birth rate after IVF or ICSI in women with diminished ovarian reserve or poor ovarian response |
| F | 18 | Fractional carbon dioxide vaginal laser (three treatment sessions) | Improved vaginal dryness, burning, and dyspareunia in genitourinary syndrome of menopause |
| F | 17 | Aspirin 300 mg oral tablet | Reduced recurrence and death after standard treatment for high-risk nonmetastatic HER2-negative breast cancer |
| F | 15 | Low-dose aspirin (acetylsalicylic acid, 75 to 100 mg, an antiplatelet nonsteroidal anti-inflammatory drug sold without prescription in some settings) | Increased live birth in women with unexplained recurrent miscarriage without antiphospholipid syndrome |
| F | 10 | Preimplantation genetic testing for aneuploidy based on embryo biopsy, a chromosome-screening strategy known as PGT-A | Increased cumulative live birth in good-prognosis IVF patients with at least three good-quality blastocysts |
| F | 10 | Alcoholic beverages in women, per 10 g/day increase in ethanol | Breast-cancer prevention or risk reduction |
| F | 8 | Glonoinum 30C (single-ingredient ultra-dilute homeopathic product) | Rapid relief of menopausal hot flashes with accompanying headache |
| F | 8 | Acupuncture as an adjunct before and after embryo transfer | Increased live-birth rate in women undergoing in vitro fertilization |
| F | 5 | Routine episiotomy (a routine policy during vaginal birth) | Prevention of severe perineal or vaginal trauma |
| ? | score not listed | Goat's rue (Galega officinalis lactation supplement) | Increased breast-milk production in lactating women |
| ? | score not listed | Mature pumpkin juice | Reduced postpartum edema |
| ? | score not listed | Miyeokguk made by rehydrating and cooking dried wakame | Faster recovery of postpartum fatigue, pain, anemia, function, or recovery time |